BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 10760109)

  • 1. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients.
    Suliman ME; Qureshi AR; Bárány P; Stenvinkel P; Filho JC; Anderstam B; Heimbürger O; Lindholm B; Bergström J
    Kidney Int; 2000 Apr; 57(4):1727-35. PubMed ID: 10760109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy.
    Suliman ME; Stenvinkel P; Heimbürger O; Bàràny P; Lindholm B; Bergström J
    Am J Kidney Dis; 2002 Sep; 40(3):480-8. PubMed ID: 12200798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus.
    Suliman ME; Stenvinkel P; Bárány P; Heimbürger O; Anderstam B; Lindholm B
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S89-95. PubMed ID: 12612961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease.
    Suliman ME; Lindholm B; Bárány P; Bergström J
    Clin Chem Lab Med; 2001 Aug; 39(8):734-8. PubMed ID: 11592443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.
    Qureshi AR; Alvestrand A; Danielsson A; Divino-Filho JC; Gutierrez A; Lindholm B; Bergström J
    Kidney Int; 1998 Mar; 53(3):773-82. PubMed ID: 9507226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
    Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
    Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
    Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients.
    Akgul A; Bilgic A; Sezer S; Arat Z; Ozdemir FN; Haberal M
    J Ren Nutr; 2008 Jul; 18(4):338-46. PubMed ID: 18558298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease.
    Suliman ME; Bárány P; Divino Filho JC; Qureshi AR; Stenvinkel P; Heimbürger O; Anderstam B; Lindholm B; Bergström J
    Nephrol Dial Transplant; 2002 Jun; 17(6):1050-6. PubMed ID: 12032196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.
    Wrone EM; Zehnder JL; Hornberger JM; McCann LM; Coplon NS; Fortmann SP
    Kidney Int; 2001 Sep; 60(3):1106-13. PubMed ID: 11532106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
    Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
    Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A
    Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
    Wollesen F; Brattström L; Refsum H; Ueland PM; Berglund L; Berne C
    Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
    Kaplan LN; Mamer OA; Hoffer LJ
    Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.